Stannard James P, Lopez-Ben Robert R, Volgas David A, Anderson Edward R, Busbee Matt, Karr Donna K, McGwin Gerald R, Alonso Jorge E
Division of Orthopaedic Surgery, University of Alabama at Birmingham, 509 Medical Education Building, 619 South 19th Street, Birmingham, AL 35294-3295, USA.
J Bone Joint Surg Am. 2006 Feb;88(2):261-6. doi: 10.2106/JBJS.D.02932.
Deep-vein thrombosis following skeletal trauma is an important yet poorly studied issue. The purpose of the present study was to evaluate the efficacy of two different strategies for prophylaxis against deep-vein thrombosis and pulmonary embolus following blunt skeletal trauma.
Two hundred and twenty-four inpatients were enrolled in a prospective, randomized study investigating venous thromboembolic disease following trauma. Two hundred patients completed the study, which compared two different regimens of prophylaxis. The patients in Group A received enoxaparin (30 mg, administered subcutaneously twice a day) starting twenty-four to forty-eight hours after blunt trauma. The patients in Group B were managed with pulsatile foot pumps at the time of admission combined with enoxaparin on a delayed basis. All patients were screened with magnetic resonance venography and ultrasonography before discharge.
There were ninety-seven patients in Group A and 103 patients in Group B. Twenty-two patients (including thirteen in Group A and nine in Group B) had development of deep-vein thrombosis, with two (both in Group A) also having development of pulmonary embolism. The prevalence of deep-vein thrombosis was 11% for the whole series, 13.4% for Group A, and 8.7% for Group B; the difference between Groups A and B was not significant. There were eleven large or occlusive clots (prevalence, 11.3%) in Group A, compared with only three (prevalence, 2.9%) in Group B (p = 0.025). The prevalence of pulmonary embolism was 2.1% in Group A and 0% in Group B. Wound complications occurred in twenty-one patients in Group A, compared with twenty patients in Group B. Patients who had development of deep-vein thrombosis during the inpatient portion of the study required a mean of 7.4 units of blood during hospitalization, compared with 3.9 units of blood for those who did not (p < 0.05).
Our results indicate that early mechanical prophylaxis with foot pumps and the addition of enoxaparin on a delayed basis is a very successful strategy for prophylaxis against venous thromboembolic disease following serious musculoskeletal injury. The prevalence of large or occlusive deep-vein thromboses among patients who had been managed with this protocol was significantly less than that among patients who had been managed with enoxaparin alone.
骨骼创伤后深静脉血栓形成是一个重要但研究较少的问题。本研究的目的是评估两种不同策略预防钝性骨骼创伤后深静脉血栓形成和肺栓塞的疗效。
224名住院患者参与了一项前瞻性随机研究,该研究调查创伤后的静脉血栓栓塞性疾病。200名患者完成了该研究,比较了两种不同的预防方案。A组患者在钝性创伤后24至48小时开始接受依诺肝素(30毫克,皮下注射,每日两次)治疗。B组患者在入院时使用搏动性足泵,并延迟使用依诺肝素。所有患者在出院前均接受磁共振静脉造影和超声检查。
A组有97名患者,B组有103名患者。22名患者(包括A组13名和B组9名)发生了深静脉血栓形成,其中2名(均在A组)还发生了肺栓塞。整个系列深静脉血栓形成的患病率为11%,A组为13.4%,B组为8.7%;A组和B组之间的差异不显著。A组有11个大血栓或闭塞性血栓(患病率为11.3%),而B组只有3个(患病率为2.9%)(p = 0.025)。A组肺栓塞的患病率为2.1%,B组为0%。A组有21名患者发生伤口并发症,B组有20名患者发生伤口并发症。在研究住院期间发生深静脉血栓形成的患者住院期间平均需要7.4单位血液,而未发生深静脉血栓形成的患者需要3.9单位血液(p < 0.05)。
我们的结果表明,早期使用足泵进行机械预防并延迟添加依诺肝素是预防严重肌肉骨骼损伤后静脉血栓栓塞性疾病的非常成功的策略。采用该方案治疗的患者中,大血栓或闭塞性深静脉血栓的患病率显著低于单独使用依诺肝素治疗的患者。